These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31700162)

  • 21. Epithelial-mesenchymal transition in undifferentiated carcinoma of the pancreas with and without osteoclast-like giant cells.
    Mattiolo P; Fiadone G; Paolino G; Chatterjee D; Bernasconi R; Piccoli P; Parolini C; El Aidi M; Sperandio N; Malleo G; Salvia R; Brosens LA; Wood LD; Scarpa A; Lawlor RT; Luchini C
    Virchows Arch; 2021 Feb; 478(2):319-326. PubMed ID: 32661742
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer.
    Yoneura N; Takano S; Yoshitomi H; Nakata Y; Shimazaki R; Kagawa S; Furukawa K; Takayashiki T; Kuboki S; Miyazaki M; Ohtsuka M
    Int J Mol Med; 2018 Aug; 42(2):821-830. PubMed ID: 29749431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Well differentiation and intact Smad4 expression are specific features of groove pancreatic ductal adenocarcinomas.
    Izumi S; Nakamura S; Mano S; Akaki S
    Pancreas; 2015 Apr; 44(3):394-400. PubMed ID: 25426619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression.
    Jones J; Mukherjee A; Karanam B; Davis M; Jaynes J; Reams RR; Dean-Colomb W; Yates C
    Cancer Lett; 2016 Oct; 380(2):513-522. PubMed ID: 27424525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells.
    Salaria SN; Illei P; Sharma R; Walter KM; Klein AP; Eshleman JR; Maitra A; Schulick R; Winter J; Ouellette MM; Goggins M; Hruban R
    Cancer Biol Ther; 2007 Mar; 6(3):324-8. PubMed ID: 17404500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of integrin β4 promotes epithelial-mesenchymal transition and is a novel prognostic marker in pancreatic ductal adenocarcinoma.
    Masugi Y; Yamazaki K; Emoto K; Effendi K; Tsujikawa H; Kitago M; Itano O; Kitagawa Y; Sakamoto M
    Lab Invest; 2015 Mar; 95(3):308-19. PubMed ID: 25599535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal adenocarcinoma of the pancreas usually retained SMAD4 and p53 protein status as well as expression of epithelial-to-mesenchymal transition markers and cell cycle regulators at the stage of liver metastasis.
    Liszka L
    Pol J Pathol; 2014 Jun; 65(2):100-12. PubMed ID: 25119169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
    Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
    J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quasimesenchymal phenotype predicts systemic metastasis in pancreatic ductal adenocarcinoma.
    Mahadevan KK; Arora KS; Amzallag A; Williams E; Kulkarni AS; Fernandez-Del Castillo C; Lillemoe KD; Bardeesy N; Hong TS; Ferrone CR; Ting DT; Deshpande V
    Mod Pathol; 2019 Jun; 32(6):844-854. PubMed ID: 30683911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer.
    Xu HL; Zhao X; Zhang KM; Tang W; Kokudo N
    World J Gastroenterol; 2014 Sep; 20(34):12171-81. PubMed ID: 25232251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.
    Biankin AV; Morey AL; Lee CS; Kench JG; Biankin SA; Hook HC; Head DR; Hugh TB; Sutherland RL; Henshall SM
    J Clin Oncol; 2002 Dec; 20(23):4531-42. PubMed ID: 12454109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Invasive carcinoma derived from intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic and immunohistochemical study of eight cases.
    Fukushima N; Mukai K; Sakamoto M; Hasebe T; Shimada K; Kosuge T; Kinoshita T; Hirohashi S
    Virchows Arch; 2001 Jul; 439(1):6-13. PubMed ID: 11499841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortalin expression in pancreatic cancer and its clinical and prognostic significance.
    Cui X; Li Z; Piao J; Li J; Li L; Lin Z; Jin A
    Hum Pathol; 2017 Jun; 64():171-178. PubMed ID: 28412209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma.
    Sopha SC; Gopal P; Merchant NB; Revetta FL; Gold DV; Washington K; Shi C
    Int J Clin Exp Pathol; 2013; 6(11):2476-86. PubMed ID: 24228110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SMAD4 expression predicts local spread and treatment failure in resected pancreatic cancer.
    Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y
    Pancreas; 2015 May; 44(4):660-4. PubMed ID: 25760429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Histologic features of venous invasion, expression of vascular endothelial growth factor and matrix metalloproteinase-2 and matrix metalloproteinase-9, and the relation with liver metastasis in pancreatic cancer.
    Nagakawa Y; Aoki T; Kasuya K; Tsuchida A; Koyanagi Y
    Pancreas; 2002 Mar; 24(2):169-78. PubMed ID: 11854622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture.
    Shichi Y; Sasaki N; Michishita M; Hasegawa F; Matsuda Y; Arai T; Gomi F; Aida J; Takubo K; Toyoda M; Yoshimura H; Takahashi K; Ishiwata T
    Sci Rep; 2019 Jul; 9(1):10871. PubMed ID: 31350453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
    Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pancreatic adenocarcinoma: the different CT criteria for peripancreatic major arterial and venous invasion.
    Li H; Zeng MS; Zhou KR; Jin DY; Lou WH
    J Comput Assist Tomogr; 2005; 29(2):170-5. PubMed ID: 15772532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.